BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38729039)

  • 1. Prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers.
    Invernizzi C; Da Silva Ribeiro Mota A; Barbe C; Bouazzi L; Marques O; Munschi L; Marchand-Crety C; Jacquin N; Dubernard X; Beddok A; Lasset C; Assouly N; Vignot S; Brenet E
    Oral Oncol; 2024 Jun; 153():106833. PubMed ID: 38729039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
    Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers.
    Topkan E; Somay E; Bascil S; Selek U
    Oral Oncol; 2024 Aug; 155():106898. PubMed ID: 38880008
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
    Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients.
    Karavolia E; van Rijn-Dekker MI; Van den Bosch L; van den Hoek JGM; Oldehinkel E; Meijer TWH; Halmos GB; Witjes MJH; Oosting SF; van der Hoorn A; Langendijk JA; Steenbakkers RJHM
    Radiother Oncol; 2022 May; 170():122-128. PubMed ID: 35304862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute toxicities experienced during simultaneous integrated boost intensity-modulated radiotherapy in head and neck cancers--experience from a north Indian regional cancer centre.
    Chakraborty S; Ghoshal S; Patil V; Oinam A; Suresh S
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):676-86. PubMed ID: 19748768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
    Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
    Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT±concurrent chemotherapy.
    Moroney LB; Helios J; Ward EC; Crombie J; Wockner LF; Burns CL; Spurgin AL; Blake C; Kenny L; Hughes BG
    Oral Oncol; 2017 Jan; 64():1-8. PubMed ID: 28024718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
    Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
    Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer.
    Mortensen HR; Overgaard J; Jensen K; Specht L; Overgaard M; Johansen J; Evensen JF; Andersen E; Andersen LJ; Hansen HS; Grau C;
    Acta Oncol; 2013 Oct; 52(7):1535-42. PubMed ID: 24047339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy.
    Meyer F; Fortin A; Wang CS; Liu G; Bairati I
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1454-62. PubMed ID: 21640495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: a single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care.
    Lambrecht M; Mercier C; Geussens Y; Nuyts S
    Support Care Cancer; 2013 Oct; 21(10):2663-70. PubMed ID: 23686379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
    Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
    Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience.
    Gupta T; Agarwal JP; Ghosh-Laskar S; Parikh PM; D'Cruz AK; Dinshaw KA
    Head Neck Oncol; 2009 Jun; 1():17. PubMed ID: 19527507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma--a prospective study.
    Hoff CM; Grau C; Overgaard J
    Radiother Oncol; 2012 Apr; 103(1):38-44. PubMed ID: 22385797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy.
    Bhide SA; Gulliford S; Fowler J; Rosenfelder N; Newbold K; Harrington KJ; Nutting CM
    Radiother Oncol; 2010 Oct; 97(1):86-91. PubMed ID: 20826031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intensity-modulated radiation therapy for head and neck cancers with bilateral irradiation of the neck : preliminary results].
    Lapeyre M; Marchesi V; Mege A; Aletti P; Graff P; Racadot S; Noel A; Marchal C
    Cancer Radiother; 2004 Jun; 8(3):134-47. PubMed ID: 15217581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
    Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.